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Ceragenins are cationic bile salt derivatives having antimicrobial activity. The interactions of several ceragenins with phospholipid bilayers
were tested in different systems. The ceragenins are capable of forming specific associations with several phospholipid species that may be
involved with their antimicrobial action. Their antimicrobial activity is lower in bacteria that have a high content of phosphatidylethanolamine.
Gram negative bacteria with a high content of phosphatidylethanolamine exhibit sensitivity to different ceragenins that corresponds to the extent of
interaction of these compounds with phospholipids, including the ability of different ceragenins to induce leakage of aqueous contents from
phosphatidylethanolamine-rich liposomes. A second class of bacteria having cell membranes composed largely of anionic lipids and having a low
content of phosphatidylethanolamine are very sensitive to the action of the ceragenins but they exhibit similar minimal inhibitory concentrations
with most of the ceragenins and for different strains of bacteria. Although Gram negative bacteria generally have a high content of
phosphatidylethanolamine, there are a few exceptions. In addition, a mutant strain of Escherichia coli has been made that is essentially devoid of
phophatidylethanolamine, although 80% of the lipid of the wild-type strain is phosphatidylethanolamine. Furthermore, certain Gram positive
bacteria are also exceptions in that they can have a high content of phosphatidylethanolamine. We find that the antimicrobial action of the
ceragenins correlates better with the content of phosphatidylethanolamine in the bacterial membrane than whether or not the bacteria has an outer
membrane. Thus, the bacterial lipid composition can be an important factor in determining the sensitivity of bacteria to antimicrobial agents.
© 2007 Elsevier B.V. All rights reserved.Keywords: Bacterial outer membrane; Cell wall; Antimicrobial agent; Bacterial membrane; Cationic sterol derivative; Gram negative bacteria;
Phosphatidylethanolamine1. Introduction
There is growing interest in developing novel antimicrobial
agents thatwould be effective againstmicrobes that are resistant to
traditional antibiotic therapy. Peptides with antimicrobial activity
have received particular attention. Some of these peptides exist in
nature as part of a natural defence system [1]. There is a large
range of chemical structures among these peptides, to the extentAbbreviations: DEPE, dielaidoylphosphatidylethanolamine; DPPC, dipal-
mitoylphosphatidylcholine; DPPG, dipalmitoylphosphatidylglycerol; DOPC,
dioleoylphosphatidylcholine; DOPG, dioleoylphosphatidylglycerol; ANTS, 8-
aminonaphthalene-1,3,6-trisulfonic acid; DPX, p-xylene-bis-pyridinium bro-
mide; CSA, Cationic Antimicrobial Steroid; PE, phosphatidylethanolamine; PG,
phosphatidylglycerol; CL, cardiolipin; PC, phosphatidylcholine
⁎ Corresponding author. Tel.: +1 905 525 9140x22073; fax: +1 905 521 1397.
E-mail address: epand@mcmaster.ca (R.M. Epand).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.05.023that more generalized rules have evaded recent efforts to optimize
their potency. One novel series of antimicrobial compounds is
based on derivatives of bile acidswith covalently attached amines.
These compounds have been termed ceragenins. Many of these
have a lipophilic moiety, facilitating their partitioning to
membranes, thought to be important either for the mechanism
of action of these agents by causing membrane damage or for
facilitating the uptake of these agents into cells. In addition,
ceragenins are polycationic, a feature important for selective
toxicity against microbes that have exposed anionic lipids.
Interestingly, there are also potent naturally occurring cationic
sterol derivatives that contribute to the microbial resistance of
sharks [2]. Ceragenins differ significantly in their toxicity against
different species of pathogenic bacteria. In the present work we
explore the relationship between the interaction of these
antimicrobial agents with model membranes of different lipid
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compositions of their cell membranes. A direct correlation
between phosphatidylethanolamine content and antimicrobial
activity has previously been found for a pair of α/β helical
peptides [3,4]. The names and structures of the ceragenins studied
in the present work are given in Fig. 1.
2. Materials and methods
2.1. Materials
Phospholipids were purchased fromAvanti Polar Lipids (Alabaster, AL). The
probes 8-aminonaphthalene-1,3,6-trisulfonic acid (ANTS) and p-xylene-bis-
pyridinium bromide (DPX) were obtained from Molecular Probes (Invitrogen).
Cationic Antimicrobial Steroid (CSA) compounds were kindly provided to us by
Ceragenix Pharmaceuticals, Denver, CO.
2.2. Bacteria
A mutant form of Escherichia coli, AD90, which has a mutated pss gene for
phosphatidylserine synthase was obtained from William Dowhan of the
University of Texas-Houston Medical School, as well as the pss+ strain
AD90/pDD72, carrying the genes for the enzymes that catalyze the biosynthesis
of phosphatidylethanolamine. Bacillus polymyxa and Bacillus cereus were
obtained from Dr. Daniel R. Zeigler of the Bacillus Genetic Stock Center of
Ohio State University and Caulobacter crescentus was obtained from Ellen M.
Quardokus, Indiana University.
2.3. Preparation of vesicles
Lipids, with or without an added ceragenin, were dissolved in chloroform/
methanol, 2/1 (v/v) at the desired lipid to ceragenin molar ratio. The solvent was
then evaporated with nitrogen to deposit a film on the wall of a glass test tube.
Final traces of solvent were removed for 2–3 h in an evacuated chamber. The
films were suspended in the appropriate buffer by vortexing at room temperature
to form multilamellar vesicles. When large unilamellar vesicles (LUVs) were
prepared, the lipid films were made devoid of ceragenins. They were hydrated
with buffer and suspensions were further processed with 5 cycles of freezing and
thawing, followed by 10 passes through two stacked 0.1 μm polycarbonate
filters (Nucleopore Filtration Products, Pleasanton, CA) in a barrel extruder
(Lipex Biomembranes, Vancouver, BC) at room temperature. LUVs were stored
on ice and used within a short time after preparation.
2.4. ANTS/DPX leakage studies
Aqueous content leakage from liposomes was determined using the ANTS/
DPX assay [5]. Lipid films were hydrated with 12.5 mM ANTS and 45 mMFig. 1. Structures of the compounds studied in this work. They are bDPX in 10 mM HEPES, pH 7.4. The osmolarity of this solution was adjusted
with NaCl to be equal to that of the assay buffer (10 mM HEPES, 0.1 mM
EDTA, pH 7.4) as measured with a cryoosmometer (Advanced Model 3MOplus
Micro-Osmometer, Advanced Instruments Inc., Norwood, MA). LUVs of
0.1 μm diameter were prepared by extrusion as described above. After passage
through a 2.5×20 cm column of Sephadex G-75, the void volume fractions were
collected and the phospholipid concentration was determined by phosphate
analysis using the method of Ames [6]. The fluorescence measurements were
performed in 2 mL of buffer in a quartz cuvette equilibrated at 37 °C with
stirring. Aliquots of LUVs were added to the cuvette and the fluorescence was
recorded as a function of time using an excitation wavelength of 360 nm and an
emission wavelength of 530 nm with 8 nm bandwidths. A 500-nm cutoff filter
was placed in the emission path. Ceragenin in buffer was added to the lipid
vesicles in the cuvette and the fluorescence monitored over time. At the end of
each experiment, the value for 100% release was obtained by adding 20 μL of a
20% Lubrol PX solution to the cuvette and sonicated briefly to achieve complete
release. Experiments were performed in duplicate; both replicates were in good
agreement. Batches of LUVs prepared on different days retained the same order
of potentiation.
2.5. Differential scanning calorimetry (DSC)
Measurements were made using a Nano II Differential Scanning Calorimeter
(Calorimetry Sciences Corporation, Lindon, UT). The scan rate was 0.75 °C/min
with a delay of 5 min between sequential scans in a series to allow for thermal
equilibration. The features of the design of this instrument have been described [7].
DSC curves were analyzed by using the fitting program, DA-2, provided by
Microcal Inc. (Northampton, MA) and plotted with Origin, version 5.0. MLVs
were prepared as described in Preparation of vesicles. The concentration ofMLVin
the samples studied was maintained at 2.5 mg/mL. The cell volume is 340 μL.
2.6. 31P NMR
The 31P NMR spectra, from suspensions of about 25 mg of lipid, with or
without added CSA-13, in PIPES buffer were obtained using a Bruker AM-500
spectrometer operating at 202.45 MHz in a 10-mm broad band probe over a 30-
kHz sweep width in 16×1024 data points. A 90° pulse width of 16.6 μs was
used. The sample was contained in a 5-mm diameter Shigemi NMR tube
(Shigemi Co., Tokyo, Japan). Composite pulse decoupling was used to remove
any proton coupling. Generally, 800 free induction decays were processed using
an exponential line broadening of 100 Hz prior to Fourier transformation. Probe
temperature was maintained to ±0.2 °C by a Bruker B-VT 1000 variable
temperature unit. Temperatures were monitored with a calibrated thermocouple
probe placed in the cavity of the NMR magnet.
2.7. Determination of minimal inhibitory concentration (MIC)
MIC values were generally determined as previously described [8]. The only
exception was the determination of the MICs for the pss+ and pss− strains ofile acid derivatives, with substitutions of different chain lengths.
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with 50 mM MgCl2 at 30 °C, conditions under which growth of the mutant
strain is optimal. MIC was determined using a broth microdilution assay.
Solutions of ceragenins in 0.02% acetic acid were kept in silanized glass
containers at an initial concentration of 2 mg/mL. This solution was diluted 10
times with sterile LB broth containing 20 mM MgCl2 and used to make serial
dilutions in 96-well sterile polypropylene untreated microplates. For the assay,
bacteria were regrown to midlog phase in LB broth supplemented with 20 mM
MgCl2 at 30 °C (exposure to less than 20 mM Mg
2+ causes lysis of the PE
minus strain) and ∼2×105 CFU/mL were added to each well. Incubation was
done at 30 °C overnight and the plate was read at 600 nm in a microplate
reader. The MIC value was the lowest concentration of ceragenin that gave no
visible bacterial growth. All MIC determinations were done in duplicate.
3. Results
3.1. DSC
We probed the interaction of a group of ceragenins with
representative lipids having headgroups found in the major lipid
components of bacterial membranes as well as the external
lipids of mammalian plasma membranes, but with acyl chains
chosen so that the phospholipid would exhibit phase transitions
at easily accessible temperatures. The lipids chosen for DSC
were DEPE, DPPC and DPPG. DSC is a powerful tool for
understanding the influence of compounds on the phase
transitions of biological membrane components. PE and PG
are major components of bacterial membranes while PC is
abundant in mammalian membranes. These studies were done
with the more active ceragenins CSA-13, CSA-54 and CSA-8.
The shifts in the phase transition temperatures with increasing
amounts of the ceragenins are summarized in Table 1.
3.2. Interaction of ceragenins with DEPE
DEPE undergoes a bilayer to inverted phase transition at
about 65 °C that can accurately be measured by calorimetry. We
have shown that the temperature of this transition (TH) is
sensitive to the presence of certain additives in the membrane
and is a reliable measure of the effects of these additives on
membrane curvature [9]. Membrane curvature in turn is knownTable 1
Linear regression of the temperature shift with mole fraction CSA in DEPE
Compound °C/mol fraction
CSA (for TM)
°C/mol fraction
CSA (for TH)
ΔHM
(kcal/mole)
ΔHH
(kcal/mole)
CSA-8 −43±9 200±18 39±10 3.5±0.5
CSA-13 −165±41 a 18±23 Not linear 0
CSA-54 −25±3 260±16 54±24 −7.3±1.3
Linear regression of the temperature shift with mole fraction CSA in DPPC
Compound TM, Heat
(°C)
TM, Cool
(°C)
ΔHM, Heat
(kcal/mole)
ΔHM, Cool
(kcal/mole)
CSA-8 −22±2 −20±2 −7.4±2 −4.6±2.4
CSA-13 Not linear Not linear Not linear Not linear
CSA-54 −9±2 −6±2 −7.9±3.3 −11.2±1.8
The temperature shift with mole fraction CSA in DPPG was not linear with any
of the 3 CSAs.
a Not linear.to play an important role in membrane fusion, including the
fusion of enveloped viruses to target membranes [10,11]. We
have shown that several substances that raise TH, inhibit viral
fusion. In the present series of compounds, however, we find
that all three ceragenins raise TH, i.e., promote positive
curvature and would therefore be expected to inhibit viral
fusion. The potency of the three compounds in raising TH is
200±20, 18±23 and 260±16, respectively, for CSA-8, 13 and
54. The most potent ceragenin, CSA-13, is the least potent in
changing curvature. Thus, positive curvature seems detrimental
to anti-bacterial activity. There may be some relationship
between membrane curvature and the antiviral activity of the
ceragenins. For example, CSA-54 that induces the greatest
positive curvature is also the most effective against Epstein–
Barr Virus and HIV. CSA-54 is however not the most potent
against vaccinia virus, although unlike Epstein–Barr Virus [12]
or HIV [13] that infect by pH-independent fusion with the
plasma membrane, vaccinia virus fusion can be promoted by
acidic pH [14] which could affect its relative degree of
inhibition by different ceragenins.
The ceragenins used in the present work also have a large
effect on the gel to liquid crystalline transition of DEPE that
appears at 37 °C for the pure lipid. With regard to this transition,
the most potent ceragenin, CSA-13, has the strongest effect in
lowering this transition temperature. This shift appears to be a
result of an increase in a lower temperature component together
with a decrease in the size (enthalpy) of the peak at 37 °C.
Furthermore, the lower temperature peak appears to become
sharper as more CSA-13 is added (Fig. 2). This behaviour
suggests the formation of a complex between the CSA-13 and
DEPE. This is not the case for CSA-54 that shows a gradual
broadening and lowering of the peak for this transition. The
behaviour of CSA-8 is intermediate. The dependence of the
temperature and enthalpy of the gel to liquid crystalline
transition, as well as the bilayer to hexagonal transition are
shown graphically (Fig. 3).
3.3. Interaction of ceragenins with DPPC
The behaviour of ceragenins was further tested using the
zwitterionic lipid dipalmitoylphosphatidylcholine (DPPC) in
place of DEPE. DPPC does not exhibit a transition to the
hexagonal phase and is a simpler system to test the effects on the
main melting transition. The results are similar to those with
DEPE but even more clear-cut (Fig. 4). Thus the broadening
and resharpening of the transition peak is dramatically seen with
CSA-13. It is also revealed by the biphasic plot of the
dependence of ΔH on the mole fraction of CSA-13 added
(Fig. 5, subscripts m and c refer to data from heating and
cooling curves).
3.4. Interaction of ceragenins with DPPG
Being cationic compounds it is expected that ceragenins
would interact strongly with anionic lipid. Indeed, all three
ceragenins showed an abrupt shift of the phase transition tempe-
rature with increasing concentration of ceragenin, concomitant
Fig. 2. DSC heating scans of DEPE with increasing mole fractions of CSA. Scan rate 0.75 o/min. Curves of excess heat capacity (cal/°C/mole) as a function of
temperature are displaced along the ordinate for ease of viewing. Left curve, CSA-8; middle curve, CSA-13; and right curve, CSA-54.
2503R.F. Epand et al. / Biochimica et Biophysica Acta 1768 (2007) 2500–2509with a biphasic effect on the gel to lamellar phase transition
enthalpy of DPPG (Fig. 6). However, they differ in the mole
fraction at which this phase separation appears, being 0.2 for
CSA-8, 0.07 for CSA-13 and 0.12 for CSA-54 (Fig. 7). Again
we find the biphasic effect to be strongest with CSA-13, the most
active ceragenin.
3.5. 31P NMR
The 31P NMR powder patterns were determined for the three
phospholipids used in the DSC studies, with and without the
addition of CSA-13. The spectra were measured as a function of
temperature. Changes with temperature were reversible, with
the major change being a broadening of the powder patternFig. 3. Dependence of the enthalpy (.H) and transition temperature for the gel to liq
DEPE on the presence of each one of the CSA compounds. Left curve, CSA-8; midbelow the gel to liquid crystalline phase transition temperature.
We present the results for a temperature slightly above the phase
transition temperature of the lipid. Only with DPPC is there
formation of a minor component corresponding to an isotropic
phase, observed as a sharp peak at 0 ppm using a high mol
fraction of 20 mol% CSA-13 (Fig. 8). In all three cases the
CSA-13 changes the shape of the powder pattern but retains a
shape corresponding to a bilayer phase.
3.6. Leakage
Leakage of aqueous contents was carried out using
liposomes made of lipid mixtures resembling the membrane
composition of several different Gram positive and Gramuid crystalline transition as well as the bilayer to hexagonal phase transition of
dle curve, CSA-13; and right curve, CSA-54.
Fig. 4. DSC heating scans of DPPC with increasing mole fractions of CSA. Scan rate 0.75 o/min. Curves are displaced along the ordinate for ease of viewing. Left
curve, CSA-8; middle curve, CSA-13; and right curve, CSA-54.
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major phospholipid components of the plasma membrane of
these cells are shown in Table 2. The outer monolayer of the
plasma membranes of mammalian cells is composed mostly of
zwitterionic lipids, such as PC and sphingomyelin, with the
anionic lipids and PE being on the inner monolayer. We have
used liposomes of DOPC as a simple model for these
membranes. Unsaturated acyl chains were used for the
phospholipids in the leakage studies to avoid effects from
phase transitions. We have also measured leakage from
liposomes having a lipid composition resembling that of the
Gram negative bacteria P. mirabilis or E. coli using a molar
ratio of 8:2 DOPE:DOPG as well as using 8:2 DOPC:DOPGFig. 5. Dependence of the enthalpy (.H) and transition temperature for the gel to liqu
Red are values from cooling scans and black from heating scans. Left curve, CSA-8to assess the importance of the nature of the zwitterionic
component. For Gram positive bacteria, we have also used a
mixture of DOPE:DOPG:CL 15:80:5 corresponding to the
membrane of B. subtilis as well as PG:CL 1:1 corresponding
to the membrane of Staphylococcus aureus or Streptococcus
pneumoniae. CSA-13 has the most potent membrane disrupt-
ing activity with liposomes having several different lipid
compositions, followed closely by CSA-54 (Fig. 9). CSA-8 is
generally less potent than either CSA-13 or CSA-54. None of
the ceragenins is expected to be haemolytic, based on their lack
of ability to induce leakage in liposomes of DOPC (Fig. 9).
Also replacement of DOPE with DOPC in 8:2 mixtures with
DOPG greatly decreases the observed leakage. In general,id crystalline transition of DPPC on the presence of one of the CSA compounds.
; middle curve, CSA-13; and right curve, CSA-54.
Fig. 6. DSC heating scans of DPPG with increasing mole fractions of CSA. Scan rate 0.75 o/min. Curves are displaced along the ordinate for ease of viewing. Left
curve, CSA-8; middle curve, CSA-13; and right curve, CSA-54.
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PG:CL 1:1.
3.7. Minimal inhibitory concentration
The MIC for the ceragenins against several bacterial species
has been previously determined (Table 3). CSA-13 is the most
potent of the compounds tested and CSA-11 and CSA-27 are
the least active. All of the ceragenins have very weak
haemolytic activity. In addition, the MICs against Gram
negative bacteria are about 10-fold higher than against Gram
positive bacteria. This contrast is most clearly seen with CSA-8.
However, there are two exceptions to this. P. mirabilis is more
resistant to these compounds than the other species, but evenFig. 7. Dependence of the enthalpy (.H) and transition temperature for the gel to liqui
Red are values from cooling scans and black from heating scans. Left curve, CSA-8more striking is the high MIC for the Gram positive bacteria,
Bacillus anthracis, that is closer to the MIC for the Gram
negative bacteria. To our knowledge, the lipid composition of
B. anthracis has not been determined. However, B. anthracis
belongs to a group of closely related bacteria that also includes
B. cereus and Bacillus thuringiensis [15]. The lipid composition
of B. cereus is known (Table 2) and it is unusually rich in PE for
a Gram positive bacteria. We have therefore determined the
consequences of changing PE content in the bacterial membrane
on their sensitivity to the ceragenin compounds.
E. coli is a Gram negative bacteria that is rich in PE (Table 2).
The primary route for the synthesis of PE in these bacteria is via
the decarboxylation of phosphatidylserine. Both the pss gene,
coding for phosphatidylserine synthetase, as well as the psdd crystalline transition of DPPG on the presence of one of the CSA compounds.
; middle curve, CSA-13; and right curve, CSA-54.
Fig. 8. 31P NMR spectra of DEPE, DPPC or DPPG with or without the addition of CSA-13. In all samples the lipid concentration was 50 mg in 400 μL.
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synthesis [16,17]. A pss− mutant of Escherichia coli has been
constructed that is viable in the absence of PE in the membrane
[18]. We have tested the antimicrobial activity of CSA-8 against
this mutant compared with that against the wild-type Escheri-
chia coli. We find no toxicity, up to 100 μg/mL, of CSA-8
against the +pss strain that contains the normal compliment ofTable 2
Major phospholipid components
Bacterial species % Total membrane phospholipid
PE PG CL PC
Gram negative bacteria
Proteus mirabilis [23] 80 10 5 –
E. coli [24] 80 15 – –
Pseudomonas aeruginosa [25] 60 21 11 –
Caulobacter crescentus a [26–28] – 40 – –
Gram positive bacteria
Bacillus polymyxa [29,30] b 60 3 8 –
Bacillus cereus [31] 43 c 40 17 –
B. anthracis d 43 40 17 –
B. subtilis [32] 12 70 4 –
S. aureus [33] – 58 42 –
S. pneumoniae [34] – 50 50 –
S. pyogenes [35] Traces – Major
component
–
Mammalian liver plasma membrane 23 e 18 f 1 39
a Neither PE or CLwere detected. Themajor lipid component of this bacteria is
monoglycosyldiglyceride, corresponding to about 45% of the lipid composition.
b Contains 26% lysolipids; 16% lysophosphatidylcholine and 10%
lysophosphatidylserine [30].
c This value corresponds to bacteria grown at 37 °C. A higher value of 50–
60% PE is generally found for this species when grown at 15 °C [31].
d Assumed to be the same as Bacillus cereus to which it is closely related
genetically [15].
e PE is on the inner monolayer of mammalian plasma membranes and not
exposed to the environment.
f Total anionic lipid=PS+PI+PA.80% PE. However, there was complete killing of the −pss strain
at a CSA-8 concentration of 25 μg/mL. Thus, although both the
+pss and −pss strains have outer membranes, the susceptibility
of the strain with a low content of PE is significantly higher than
the wild-type strain.
In order to further probe the relationship between the PE
content of the bacteria and microbial resistance, we sought
species of bacteria that were exceptions to the generalization
that Gram negative bacteria are rich in PE and Gram positive are
poor in PE. We already discussed one such example, B.
anthracis. B. cereus and B. polymyxa are two other Gram
positive bacteria with high PE. In addition, C. crescentus is an
example of a Gram negative bacteria with low PE. The MICs for
these bacteria were determined as part of the present study,
under the same uniform conditions. The MIC values obtained
for these bacteria species were compared with values obtained
previously reported for CSA-8 against other species and good
agreement was found with previous results. The new MICFig. 9. CSA-induced aqueous contents leakage from liposomes of different lipid
compositions. Leakage measured at 200 s using 10 μMCSA at a phospholipid to
CSA ratio of 5.
Table 3
Organism MIC Values (μg/mL) of Ceragenins a
CSA-13 CSA-54 CSA-8 CSA-11 CSA-27
Gram negative bacteria
Proteus mirabilis 16 500 500 ND ND
E. coli 3.0 7.0 36 80 85
P. aeruginosa 2.0 ND 20 85 ND
Gram positive bacteria
B. anthracis 2.5 ND 20 ND ND
S. aureus 0.4 2.0 2.0 9.0 ND
S. pyogenes 0.5 0.5 0.5 ND ND
B. subtilis 0.5 1 0.5 ND ND
Hemolysis
Minimum hemolytic
concentration
30 N100 100 N100 ND
ND=Not Determined.
a Data taken from [8,36–39] and provided by C. Genberg of Ceragenix
Pharmaceuticals, Inc.
Table 4
CSA-8 MIC and PE content
Bacteria MIC (μg/mL) % PE
Gram negative bacteria
Proteus mirabilis 500 80
Escherichia coli 36 80
Pseudomonas aeruginosa 20 60
Caulobacter crescentus 5 ∼0
Gram positive bacteria
Bacillus polymyxa 35 60
B. anthracis 20 43
Bacillus cereus 50 43
Bacillus subtilis 0.5 12
S. aureus 2 ∼0
S. pyogenes 0.5 ∼0
2507R.F. Epand et al. / Biochimica et Biophysica Acta 1768 (2007) 2500–2509values in μg/mL for B. polymyxa, B. cereus, and C. crescentus
are 35, 50 and 5, respectively.
4. Discussion
There are a wide range of cationic antimicrobial agents
believed to produce toxic effects by several different mechan-
isms [19]. A common element among these agents is their
positive charge that is believed to contribute to the specificity
toward prokaryotes that have exposed anionic lipids. The
mechanism of CSA-8 has been compared with that of certain
cationic peptides [20]. CSA-8 causes depolarization of bacterial
membranes at rates similar to that of magainin I, although at
much lower concentration. CSA-8 also stimulates the activation
of the same bacterial promoters as does cecropin. Also similar to
many cationic antimicrobial peptides, CSA-8 also shows, by
electron microscopy, the disruption of bacterial membranes. It
thus seems likely that there is a relationship between the
mechanism of action of the ceragenins and that of certain
cationic antimicrobial peptides.
Cationic antimicrobial agents differ greatly in their selectiv-
ity for different bacteria. There are some agents that exhibit a
broad range of antimicrobial action including both Gram
positive as well as Gram negative bacteria. However, there are
also agents, such as polymyxin, that are selective for Gram
negative bacteria because they have an affinity for a component
of the outer membrane [21]. There are also several cationic
peptides, as well as the ceragenins, that have higher toxicity
against Gram positive bacteria than against Gram negative
bacteria. It is often assumed that the outer membrane of Gram
negative bacteria affords them greater protection by preventing
access of antimicrobial agents to the inner membrane. However,
this does not appear to be the case with CSA-8, since removal of
PE in the pss− mutant of E. coli leads to increased sensitivity to
this antimicrobial agent. The −pss strain has an outer membrane
as well as the same protein content and composition and acyl
chain composition as the +pss form [17]. The −pss mutant hasan increase in cardiolipin content that could cause an increase in
susceptibility to toxic cationic agents. However, these cells can
only be grown at very high concentrations of Mg2+, above
20 mM! It is therefore likely that the divalent cations will screen
the electrostatic interactions between CSA-8 and the cell
membrane. This also explains why the +pss mutant has
resistance to CSA-8 up to 100 μg/mL when the MIC is
determined in the presence of 20 mM Mg2+. What can be
concluded is that even though the outer membrane is still
present, the pss− mutants have greater susceptibility to CSA-8.
We suggest that this must be a consequence of the loss of PE
from the plasma membrane.
Although generally Gram positive bacteria have a low PE
content in their membranes and Gram negative bacteria have a
high PE content, exceptions can be found.
B. polymyxa, B. cereus and consequently also B. anthracis
have a relatively high content of PE, although they are Gram
positive bacteria (Table 2). C. crescentus is an example of a
Gram negative bacteria with a low content of PE (Table 2). The
MIC values for CSA-8 appear to be more closely related to the
PE content of the bacteria than to the presence or absence of an
outer membrane (Table 4). Thus the three Bacilli with high PE
have MICs comparable to most of the Gram negative bacteria,
while C. crescentuswith a low PE has a lowMIC comparable to
that of the majority of Gram positive bacteria. P. mirabilis has a
higher MIC than other Gram negative bacteria, possibly
because the outer membrane contributes more to resistance
for this bacterium than for others. It should also be noted that
bacteria with high PE will also have less anionic lipid and this
could contribute to the higher resistance of these organisms. The
fact that the pss− mutants have lower resistance to CSA-8 does
not negate this possibility since these assays had to be
performed at very high concentrations of divalent cations
where the role of charge interactions is likely reduced.
We have further probed the mechanism of action of CSA-8
and its relationship with other ceragenins. There is a relationship
between the potency of the ceragenin against Gram negative
bacteria having a high PE content and its ability to induce
leakage in liposomes having a similar lipid composition of
DOPE:DOPG (80:20) (Fig. 9). Thus CSA-8 is always less potent
than CSA-13 for several Gram negative bacteria (Table 3) and its
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with 80% PE (Fig. 9). The situation is less clear for CSA-54 that
has a MIC close to CSA-8 with P. mirabilis, where other factors
may come into play, but has a MIC close to that of CSA-13 and
its leakage potency with these liposomes is like that of CSA-13.
In addition, all of the ceragenins are weakly haemolytic (high
minimal concentration required to induce hemolysis), with
CSA-13 being the most haemolytic among these compounds
(Table 3). This is also in accord with the observation that none of
the ceragenins is very effective in causing lysis to zwitterionic
liposomes of phosphatidylcholine alone or with DOPC as the
major component, although among the ceragenins tested, CSA-
13 is again the most effective (Fig. 9).
Except for B. anthracis, the MICs for the other three Gram
positive bacteria are all low and insensitive to the structure of
the ceragenins, and are also similar for all three bacterial species
(Table 3). Despite this, leakage studies with liposomes having
the lipid composition of B. subtilis, i.e. PE:PG:CL (15:80:5)
show large differences in leakage potency among the ceragenins
(Fig. 9). This is also true for leakage induced in liposomes
resembling the lipid composition of S. aureus, i.e. PG:CL (1:1)
that shows a much wider variation among the ceragenins (Fig.
9) that does not correspond to the narrow range of MIC values
for these bacteria (Table 3).
There thus appears to be two different mechanisms of actions
of the ceragenins. One being of lower potency against bacteria
with a high PE content that correlates with liposomal leakage
and the other being of higher potency against bacteria that have
membranes composed predominantly of anionic lipids. The
bacteria with a low PE content are killed by the ceragenins by a
mechanism that does not correlate with membrane leakage,
suggesting that it is not through the formation of pores in the
bacteria. This mechanism is insensitive to the structure of the
ceragenins or even of the overall charge on the ceragenin.
Electrostatic interactions of the ceragenins with anionic lipids or
with LPS would be expected. However, the MICs of CSA-54
and CSA-8 are the same against S. aureus (Table 3), even
though CSA-54 has a charge of +6 compared with +3 for CSA-
8. Unlike the antimicrobial activity, charge on the ceragenin may
contribute to the extent of liposomal leakage. For example, the
leakage induced in the liposomes of PG:CL (1:1) by CSA-54 is
much greater with CSA-8. This may also explain why CSA-27,
having a charge of +6, although generally found to have weak
antimicrobial activity is potent in inducing leakage in the PG:CL
lipid mixture (Fig. 9). Thus charge is not the only factor
determining the antimicrobial activity, even against S. aureus, a
bacterium having a membrane composed almost entirely of
anionic lipids.
It is striking that the change from DOPE:DOPG (8:2) to
DOPC:DOPG (8:2) results in a dramatic loss in the membrane
rupturing capacity of the ceragenins. The structural difference
between PE and PC is that an ammonium group (−NH3+) is
changed to a trimethylammonium group (−N(CH3)3+). Hydro-
gen bonding with the N–H bonds in PE may occur, while a
similar interaction is not possible with PC. Membrane curvature
effects may also play a role. If the ceragenins act by forming a
pore lined with both lipid and ceragenin, it would be anticipatedthat pore formation would be facilitated by drugs that promote
positive membrane curvature as has been found with magainin
[22]. However, all three of the ceragenins tested, CSA-8, CSA-
13 and CSA-54 raise the bilayer to hexagonal phase transition
temperature of DEPE by 200±20, 18±23 and 257±16,
respectively. The observation that the curvature effects are
smallest for the most potent CSA-13 suggests that promotion of
positive curvature may inhibit the action of these compounds
against bacteria with a high PE content.
One physical property that is particular to the ceragenins is
the effect they have on the gel to liquid crystalline phase
transition of DPPC and DPPG. Usually when an additive is
introduced to a pure lipid component, the melting behaviour of
the pure component is broadened, demonstrating that the
transition is becoming less cooperative. However, in the case of
the ceragenins, their interactions with both DPPC and DPPG
show an initial broadening followed by the formation of a
component with a new transition temperature and high
cooperativity. Although not identical, the three ceragenins
tested behaved in a similar manner with both DPPC and with
DPPG. This property may contribute in some way to the
antimicrobial activity of these compounds since the most potent
analog, CSA-13, is also the ceragenin that affects the phase
transitions at the lowest concentration. CSA-13 is also the only
ceragenin that promotes formation of a new cooperative
transition with DEPE at lower temperature (Fig. 2), indicating
that it also forms complexes with PE. We also measured the 31P
NMR powder patterns with these mixtures and observed that
CSA-13 did not induce the formation of non-lamellar phases,
although they did modify the shape of the powder patterns
without affecting the chemical shift anisotropy (Fig. 8). There is
also another unique feature of the interaction of CSA-13 with
the zwitterionic lipids, DEPE and DPPC. The ΔH of the main
transition of these lipids changes in a biphasic fashion for CSA-
13, while for CSA-8 and CSA-54 there is a monotonic increase
of ΔH with increasing mol fraction of ceragenin with both
DEPE (Fig. 3) and with DPPC (Fig. 5). This unique feature
indicates that CSA-13 has specific interactions with phos-
pholipids, a property that may contribute to its antimicrobial
potency.
Thus, there is a relationship between the antimicrobial
activity of these compounds and the lipid composition of a
bacterial membrane. Bacteria with high PE content are more
resistant to the action of these agents. Among the different
ceragenins, those that are more effective in rupturing liposomes
with a high PE content also have lower MICs for these bacteria
with high PE. Since the ceragenins have a conformationally
restricted fused ring structure and chemically modified forms
are relatively easy to synthesize, the increased understanding of
their specificity and mode of action provided by the present
work will contribute to the design of new analogs with
increased potency and broader range of activity.
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